Oncogene Amplification Detection

Oncogene amplification detection identifies malignant cells with excessive gene copies driving proliferation. Fluorescence in situ hybridisation visualises gene copy numbers. Quantitative PCR quantitates copy number increases. NGS sequencing detects amplified regions. Copy number variations predict treatment response.

Companion diagnostics commercialised with therapeutics identify amplified tumours. Regulatory submissions incorporate amplification assessment. Clinical outcomes stratify by amplification status. Post-approval monitoring identifies amplification-related patterns. Emerging cytogenetic technologies improve detection.